ARTICLE | Clinical News
S-8184: Began Phase I testing
January 16, 2001 8:00 AM UTC
Sonus Pharmaceuticals Inc. (SNUS), Bothell, Wash. Product: S-8184 Business: Cancer Therapeutic category: Cytotoxic Target: Spindle microtubules Description: Paclitaxel formulated with Tocosol drug del...